{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T19:20:39Z","timestamp":1778700039833,"version":"3.51.4"},"reference-count":103,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Veterinary Clinics of North America: Small Animal Practice"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.cvsm.2018.07.002","type":"journal-article","created":{"date-parts":[[2018,8,21]],"date-time":"2018-08-21T05:50:56Z","timestamp":1534830656000},"page":"991-1012","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Toxicology of Avermectins and Milbemycins (Macrocyclic Lactones) and the Role of P-Glycoprotein in Dogs and Cats"],"prefix":"10.1016","volume":"48","author":[{"given":"Valentina M.","family":"Merola","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul A.","family":"Eubig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cvsm.2018.07.002_bib1","series-title":"Macrocyclic lactones in antiparasitic therapy","year":"2002"},{"key":"10.1016\/j.cvsm.2018.07.002_bib2","series-title":"Veterinary pharmacology and therapeutics","first-page":"1119","article-title":"Macrocyclic lactones: endectocide compounds","author":"Lanusse","year":"2009"},{"key":"10.1016\/j.cvsm.2018.07.002_bib3","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/arch.10112","article-title":"Chloride channels as tools for developing selective insecticides","volume":"54","author":"Bloomquist","year":"2003","journal-title":"Arch Insect Biochem Physiol"},{"key":"10.1016\/j.cvsm.2018.07.002_bib4","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S1054-3589(06)54010-4","article-title":"Structure, pharmacology, and function of GABAA receptor subtypes","volume":"54","author":"Sieghart","year":"2006","journal-title":"Adv Pharmacol"},{"key":"10.1016\/j.cvsm.2018.07.002_bib5","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0031-6997(25)06840-1","article-title":"Structure and pharmacology of gamma-aminobutyric acid A receptor subtypes","volume":"47","author":"Sieghart","year":"1995","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.cvsm.2018.07.002_bib6","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1292\/jvms.10-0424","article-title":"Central and peripheral neurotoxic effects of ivermectin in rats","volume":"73","author":"Trailovic","year":"2011","journal-title":"J\u00a0Vet Med Sci"},{"key":"10.1016\/j.cvsm.2018.07.002_bib7","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.vetpar.2008.09.009","article-title":"Canine ABCB1 and macrocyclic lactones: heartworm prevention and pharmacogenetics","volume":"158","author":"Mealey","year":"2008","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.cvsm.2018.07.002_bib8","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev.genom.6.080604.162122","article-title":"Evolution of the ATP-binding cassette (ABC) transporter superfamily in vertebrates","volume":"6","author":"Dean","year":"2005","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"10.1016\/j.cvsm.2018.07.002_bib9","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1177\/030098589603300508","article-title":"Immunohistochemical detection of P-glycoprotein in formalin-fixed and paraffin-embedded normal and neoplastic canine tissues","volume":"33","author":"Ginn","year":"1996","journal-title":"Vet Pathol"},{"key":"10.1016\/j.cvsm.2018.07.002_bib10","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1439-0264.2009.00972.x","article-title":"Tissue distribution of p-glycoprotein in cats","volume":"38","author":"Van Der Heyden","year":"2009","journal-title":"Anat Histol Embryol"},{"key":"10.1016\/j.cvsm.2018.07.002_bib11","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s00204-007-0193-6","article-title":"Potential impact of ABCB1 (p-glycoprotein) polymorphisms on avermectin toxicity in humans","volume":"81","author":"Macdonald","year":"2007","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.cvsm.2018.07.002_bib12","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1124\/dmd.107.018978","article-title":"P-glycoprotein contributes to the blood-brain, but not blood-cerebrospinal fluid, barrier in a spontaneous canine p-glycoprotein knockout model","volume":"36","author":"Mealey","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.cvsm.2018.07.002_bib13","first-page":"600","article-title":"Physiology and pharmacological role of the blood-brain barrier","volume":"60","author":"Bernacki","year":"2008","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.cvsm.2018.07.002_bib14","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s00228-009-0714-8","article-title":"Blood-brain barrier transporters and response to CNS-active drugs","volume":"65","author":"Urquhart","year":"2009","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.cvsm.2018.07.002_bib15","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/00008571-200111000-00012","article-title":"Ivermectin sensitivity in collies is associated with a deletion mutation of the mdr1 gene","volume":"11","author":"Mealey","year":"2001","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.cvsm.2018.07.002_bib16","series-title":"Plumb's veterinary drug handbook","author":"Plumb","year":"2005"},{"key":"10.1016\/j.cvsm.2018.07.002_bib17","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2460\/javma.233.2.279","article-title":"Retinopathy associated with ivermectin toxicosis in two dogs","volume":"233","author":"Kenny","year":"2008","journal-title":"J\u00a0Am Vet Med Assoc"},{"key":"10.1016\/j.cvsm.2018.07.002_bib18","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.2460\/javma.246.11.1238","article-title":"Retinopathy associated with ivermectin toxicosis in five cats","volume":"246","author":"Meekins","year":"2015","journal-title":"J\u00a0Am Vet Med Assoc"},{"key":"10.1016\/j.cvsm.2018.07.002_bib19","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1053\/tvjl.2000.0521","article-title":"Faecal excretion profile of moxidectin and ivermectin after oral administration in horses","volume":"161","author":"Perez","year":"2001","journal-title":"Vet J"},{"key":"10.1016\/j.cvsm.2018.07.002_bib20","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1365-2885.1987.tb00083.x","article-title":"Response to physostigmine administration in collie dogs exhibiting ivermectin toxicosis","volume":"10","author":"Tranquilli","year":"1987","journal-title":"J\u00a0Vet Pharmacol Ther"},{"key":"10.1016\/j.cvsm.2018.07.002_bib21","doi-asserted-by":"crossref","first-page":"78","DOI":"10.2460\/javma.1987.191.01.78","article-title":"Ivermectin toxicosis in a dog","volume":"191","author":"Houston","year":"1987","journal-title":"J\u00a0Am Vet Med Assoc"},{"key":"10.1016\/j.cvsm.2018.07.002_bib22","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.2460\/javma.1995.206.08.1147","article-title":"Ivermectin toxicosis in two Australian shepherds","volume":"206","author":"Hadrick","year":"1995","journal-title":"J\u00a0Am Vet Med Assoc"},{"key":"10.1016\/j.cvsm.2018.07.002_bib23","doi-asserted-by":"crossref","first-page":"106","DOI":"10.5326\/0450106","article-title":"Ivermectin toxicosis in dogs: a retrospective study","volume":"45","author":"Merola","year":"2009","journal-title":"J\u00a0Am Anim Hosp Assoc"},{"key":"10.1016\/j.cvsm.2018.07.002_bib24","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2460\/javma.1990.197.01.93","article-title":"Ivermectin toxicosis in a dog","volume":"197","author":"Hopkins","year":"1990","journal-title":"J\u00a0Am Vet Med Assoc"},{"key":"10.1016\/j.cvsm.2018.07.002_bib25","doi-asserted-by":"crossref","first-page":"921","DOI":"10.2460\/javma.233.6.921","article-title":"Breed distribution of the ABCB1-1Delta (multidrug sensitivity) polymorphism among dogs undergoing ABCB1 genotyping","volume":"233","author":"Mealey","year":"2008","journal-title":"J\u00a0Am Vet Med Assoc"},{"key":"10.1016\/j.cvsm.2018.07.002_bib26","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2460\/javma.1991.199.04.457","article-title":"Evaluation of the safety of ivermectin administered in a beef-based formulation to ivermectin-sensitive Collies","volume":"199","author":"Fassler","year":"1991","journal-title":"J\u00a0Am Vet Med Assoc"},{"key":"10.1016\/j.cvsm.2018.07.002_bib27","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1939-1676.2002.tb01611.x","article-title":"Ivermectin toxicity in 17 collies","volume":"16","author":"Hopper","year":"2002","journal-title":"J\u00a0Vet Intern Med"},{"key":"10.1016\/j.cvsm.2018.07.002_bib28","doi-asserted-by":"crossref","first-page":"584","DOI":"10.2460\/javma.1994.205.04.584","article-title":"Ivermectin toxicosis in a kitten","volume":"205","author":"Lewis","year":"1994","journal-title":"J\u00a0Am Vet Med Assoc"},{"key":"10.1016\/j.cvsm.2018.07.002_bib29","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1751-0813.2009.00448.x","article-title":"Toxicity in three dogs from accidental oral administration of a topical endectocide containing moxidectin and imidacloprid","volume":"87","author":"See","year":"2009","journal-title":"Aust Vet J"},{"key":"10.1016\/j.cvsm.2018.07.002_bib30","first-page":"181","article-title":"Moxidectin toxicosis in a puppy successfully treated with intravenous lipids","volume":"19","author":"Crandell","year":"2009","journal-title":"J\u00a0Vet Emerg Crit Care (San Antonio)"},{"key":"10.1016\/j.cvsm.2018.07.002_bib31","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/j.1748-5827.2006.00081.x","article-title":"Clinical presentation and management of moxidectin toxicity in two dogs","volume":"47","author":"Snowden","year":"2006","journal-title":"J\u00a0Small Anim Pract"},{"key":"10.1016\/j.cvsm.2018.07.002_bib32","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.2460\/javma.1999.215.12.1813","article-title":"Respiratory failure attributable to moxidectin intoxication in a dog","volume":"215","author":"Beal","year":"1999","journal-title":"J\u00a0Am Vet Med Assoc"},{"key":"10.1016\/j.cvsm.2018.07.002_bib33","unstructured":"Woodward KN. Joint WHO\/FAO Expert Committee on Food Additives. 771. Ivermectin (WHO Food Additives Series 31). 1993. Available at: http:\/\/www.inchem.org\/documents\/jecfa\/jecmono\/v31je03.htm. Accessed June 11, 2018."},{"key":"10.1016\/j.cvsm.2018.07.002_bib34","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.2460\/ajvr.1991.52.07.1170","article-title":"Assessment of toxicosis induced by high-dose administration of milbemycin oxime in collies","volume":"52","author":"Tranquilli","year":"1991","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.cvsm.2018.07.002_bib35","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1365-3164.2008.00725.x","article-title":"ABCB1-1 Delta (MDR1-1 Delta) genotype is associated with adverse reactions in dogs treated with milbemycin oxime for generalized demodicosis","volume":"20","author":"Barbet","year":"2009","journal-title":"Vet Dermatol"},{"key":"10.1016\/j.cvsm.2018.07.002_bib36","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00436-007-0776-4","article-title":"Efficacy of eprinomectin against Toxacara canis in dogs","volume":"102","author":"Kozan","year":"2008","journal-title":"Parasitol Res"},{"key":"10.1016\/j.cvsm.2018.07.002_bib37","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0304-4017(89)90055-1","article-title":"Efficacy of nemadectin, a new broad-spectrum endectocide, against natural infections of canine gastrointestinal helminths","volume":"34","author":"Doscher","year":"1989","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.cvsm.2018.07.002_bib38","first-page":"718","article-title":"Doramectin toxicity in a collie","volume":"153","author":"Yas-Natan","year":"2003","journal-title":"Vet Rec"},{"key":"10.1016\/j.cvsm.2018.07.002_bib39","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1365-2885.2007.00885.x","article-title":"Detection of the nt230(del4) MDR1 mutation in White Swiss Shepherd dogs: case reports of doramectin toxicosis, breed predisposition, and microsatellite analysis","volume":"30","author":"Geyer","year":"2007","journal-title":"J\u00a0Vet Pharmacol Ther"},{"key":"10.1016\/j.cvsm.2018.07.002_bib40","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1365-2885.1996.tb00062.x","article-title":"Avermectins and milbemycins","volume":"19","author":"McKellar","year":"1996","journal-title":"J\u00a0Vet Pharmacol Ther"},{"key":"10.1016\/j.cvsm.2018.07.002_bib41","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.rvsc.2008.08.005","article-title":"Pharmacokinetics of ivermectin in cats receiving a single subcutaneous dose","volume":"86","author":"Chittrakarn","year":"2009","journal-title":"Res Vet Sci"},{"key":"10.1016\/j.cvsm.2018.07.002_bib42","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s002280050131","article-title":"Ivermectin distribution in the plasma and tissues of patients infected with Onchocerca volvulus","volume":"50","author":"Baraka","year":"1996","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.cvsm.2018.07.002_bib43","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.tvjl.2007.07.011","article-title":"The pharmacokinetics and metabolism of ivermectin in domestic animal species","volume":"179","author":"Gonz\u00e1lez Canga","year":"2009","journal-title":"Vet J"},{"issue":"3\u20134","key":"10.1016\/j.cvsm.2018.07.002_bib44","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.vetpar.2005.10.002","article-title":"Comparative plasma dispositions of ivermectin and doramectin following subcutaneous and oral administration in dogs","volume":"135","author":"Gokbulut","year":"2006","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.cvsm.2018.07.002_bib45","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/bdd.572","article-title":"Comparison of the pharmacokinetics of moxidectin and ivermectin after oral administration to beagle dogs","volume":"28","author":"Al-Azzam","year":"2007","journal-title":"Biopharm Drug Dispos"},{"issue":"8\u20139","key":"10.1016\/j.cvsm.2018.07.002_bib46","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/j.fct.2010.05.043","article-title":"Comparative pharmacokinetics of some injectable preparations containing ivermectin in dogs","volume":"48","author":"Eraslan","year":"2010","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.cvsm.2018.07.002_bib47","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/bdd.313","article-title":"Pharmacokinetics and dose proportionality of oral moxidectin in beagle dogs","volume":"23","author":"Vanapalli","year":"2002","journal-title":"Biopharm Drug Dispos"},{"key":"10.1016\/j.cvsm.2018.07.002_bib48","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1365-2885.2007.00878.x","article-title":"Estimation of absolute oral bioavailability of moxidectin in dogs using a semi-simultaneous method: influence of lipid co-administration","volume":"30","author":"Lallemand","year":"2007","journal-title":"J\u00a0Vet Pharmacol Ther"},{"key":"10.1016\/j.cvsm.2018.07.002_bib49","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1046\/j.1365-2885.2002.00415.x","article-title":"Pharmacokinetics of selamectin following intravenous, oral and topical administration in cats and dogs","volume":"25","author":"Sarasola","year":"2002","journal-title":"J\u00a0Vet Pharmacol Ther"},{"key":"10.1016\/j.cvsm.2018.07.002_bib50","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1365-2885.2008.00964.x","article-title":"The pharmacogenomics of P-glycoprotein and its role in veterinary medicine","volume":"31","author":"Martinez","year":"2008","journal-title":"J\u00a0Vet Pharmacol Ther"},{"key":"10.1016\/j.cvsm.2018.07.002_bib51","doi-asserted-by":"crossref","first-page":"272","DOI":"10.2174\/138920009787846297","article-title":"Interaction of macrocyclic lactones with the multidrug transporters: the bases of the pharmacokinetics of lipid-like drugs","volume":"10","author":"Lespine","year":"2009","journal-title":"Curr Drug Metab"},{"key":"10.1016\/j.cvsm.2018.07.002_bib52","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1080\/10408440802004049","article-title":"P-glycoprotein efflux transporter activity often displays biphasic dose-response relationships","volume":"38","author":"Calabrese","year":"2008","journal-title":"Crit Rev Toxicol"},{"key":"10.1016\/j.cvsm.2018.07.002_bib53","doi-asserted-by":"crossref","first-page":"769","DOI":"10.2460\/ajvr.1989.50.05.769","article-title":"Ivermectin plasma concentrations in collies sensitive to ivermectin-induced toxicosis","volume":"50","author":"Tranquilli","year":"1989","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.cvsm.2018.07.002_bib54","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1365-2885.2009.01068.x","article-title":"Biliary excretion of technetium-99m-sestamibi in wild-type dogs and in dogs with intrinsic (ABCB1-1Delta mutation) and extrinsic (ketoconazole treated) P-glycoprotein deficiency","volume":"32","author":"Coelho","year":"2009","journal-title":"J\u00a0Vet Pharmacol Ther"},{"key":"10.1016\/j.cvsm.2018.07.002_bib55","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1365-2885.2010.01170.x","article-title":"Oral bioavailability of P-glycoprotein substrate drugs do not differ between ABCB1-1Delta and ABCB1 wild type dogs","volume":"33","author":"Mealey","year":"2010","journal-title":"J\u00a0Vet Pharmacol Ther"},{"key":"10.1016\/j.cvsm.2018.07.002_bib56","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.vetpar.2005.05.004","article-title":"Frequency of the mutant MDR1 allele associated with multidrug sensitivity in a sample of herding breed dogs living in Australia","volume":"131","author":"Mealey","year":"2005","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.cvsm.2018.07.002_bib57","first-page":"341","article-title":"Novel insertion mutation of ABCB1 gene in an ivermectin-sensitive Border Collie","volume":"11","author":"Han","year":"2010","journal-title":"J\u00a0Vet Sci"},{"key":"10.1016\/j.cvsm.2018.07.002_bib58","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1365-3164.2008.00731.x","article-title":"The ABCB1-1Delta mutation is not responsible for subchronic neurotoxicity seen in dogs of non-collie breeds following macrocyclic lactone treatment for generalized demodicosis","volume":"20","author":"Bissonnette","year":"2009","journal-title":"Vet Dermatol"},{"key":"10.1016\/j.cvsm.2018.07.002_bib59","first-page":"311","article-title":"Multiple oral dosing of ketoconazole increases dog exposure to ivermectin","volume":"10","author":"Hugnet","year":"2007","journal-title":"J\u00a0Pharm Pharm Sci"},{"key":"10.1016\/j.cvsm.2018.07.002_bib60","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1124\/dmd.110.034827","article-title":"Pharmacokinetic interaction of the antiparasitic agents ivermectin and spinosad in dogs","volume":"39","author":"Dunn","year":"2011","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.cvsm.2018.07.002_bib61","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2460\/ajvr.71.1.115","article-title":"Evaluation of the safety of spinosad and milbemycin 5-oxime orally administered to Collies with the MDR1 gene mutation","volume":"71","author":"Sherman","year":"2010","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.cvsm.2018.07.002_bib62","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1046\/j.1440-1681.1999.02987.x","article-title":"Barrier mechanisms in the brain, II. Immature brain","volume":"26","author":"Saunders","year":"1999","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.cvsm.2018.07.002_bib63","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/ar.1092150109","article-title":"Telencephalic microvessels of premature beagle pups","volume":"215","author":"Leuschen","year":"1986","journal-title":"Anat Rec"},{"key":"10.1016\/j.cvsm.2018.07.002_bib64","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1055\/s-0028-1103272","article-title":"ABC transporter (P-gp\/ABCB1, MRP1\/ABCC1, BCRP\/ABCG2) expression in the developing human CNS","volume":"39","author":"Daood","year":"2008","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.cvsm.2018.07.002_bib65","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000047185","article-title":"P-glycoprotein expression in mouse brain increases with maturation","volume":"81","author":"Tsai","year":"2002","journal-title":"Biol Neonate"},{"key":"10.1016\/j.cvsm.2018.07.002_bib66","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/j.neurobiolaging.2009.08.014","article-title":"Age-dependent decline of blood-brain barrier P-glycoprotein expression in the canine brain","volume":"32","author":"Pekcec","year":"2011","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.cvsm.2018.07.002_bib67","first-page":"667","article-title":"Intravenous lipid emulsion therapy in 20 cats accidentally overdosed with ivermectin","volume":"25","author":"Jourdan","year":"2015","journal-title":"J\u00a0Vet Emerg Crit Care (San Antonio)"},{"key":"10.1016\/j.cvsm.2018.07.002_bib68","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1939-1676.2003.tb02491.x","article-title":"A\u00a0review of methods for assessment of the rate of gastric emptying in the dog and cat: 1898-2002","volume":"17","author":"Wyse","year":"2003","journal-title":"J\u00a0Vet Intern Med"},{"key":"10.1016\/j.cvsm.2018.07.002_bib69","series-title":"Activated charcoal in medical applications","first-page":"85","author":"Cooney","year":"1995"},{"key":"10.1016\/j.cvsm.2018.07.002_bib70","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0195-5616(90)50027-3","article-title":"Management of toxicoses","volume":"20","author":"Beasley","year":"1990","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"10.1016\/j.cvsm.2018.07.002_bib71","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0195-5616(90)50038-8","article-title":"Ivermectin and piperazine toxicoses in dogs and cats","volume":"20","author":"Lovell","year":"1990","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"10.1016\/j.cvsm.2018.07.002_bib72","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1067\/mem.2002.122058","article-title":"The role of activated charcoal and gastric emptying in gastrointestinal decontamination: a state-of-the-art review","volume":"39","author":"Bond","year":"2002","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.cvsm.2018.07.002_bib73","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1067\/mem.2003.86","article-title":"The frequency of complications associated with the use of multiple-dose activated charcoal","volume":"41","author":"Dorrington","year":"2003","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.cvsm.2018.07.002_bib74","series-title":"Small animal toxicology","first-page":"785","article-title":"Ivermectin: macrolide antiparasitic agents","author":"Mealey","year":"2006"},{"key":"10.1016\/j.cvsm.2018.07.002_bib75","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.drudis.2009.06.009","article-title":"The complexity of the GABAA receptor shapes unique pharmacological profiles","volume":"14","author":"D'Hulst","year":"2009","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.cvsm.2018.07.002_bib76","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/vr.101036","article-title":"Lipid infusion in the management of poisoning: a report of 6 canine cases","volume":"172","author":"Bates","year":"2013","journal-title":"Vet Rec"},{"key":"10.1016\/j.cvsm.2018.07.002_bib77","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.2460\/javma.239.10.1328","article-title":"Use of intravenous lipid emulsion to treat ivermectin toxicosis in a Border Collie","volume":"239","author":"Clarke","year":"2011","journal-title":"J\u00a0Am Vet Med Assoc"},{"key":"10.1016\/j.cvsm.2018.07.002_bib78","first-page":"725","article-title":"Intravenous fat emulsion (IFE) for treatment of ivermectin toxicosis in 3 dogs ACVIM Forum abstract N-1","volume":"25","author":"Wright","year":"2011","journal-title":"J\u00a0Vet Intern Med"},{"key":"10.1016\/j.cvsm.2018.07.002_bib79","first-page":"58","article-title":"Ivermectin-induced blindness treated with intravenous lipid therapy in a dog","volume":"23","author":"Epstein","year":"2013","journal-title":"J\u00a0Vet Emerg Crit Care (San Antonio)"},{"key":"10.1016\/j.cvsm.2018.07.002_bib80","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/vop.12410","article-title":"Electroretinographic changes after intravenous lipid emulsion therapy in a dog and a foal with ivermectin toxicosis","volume":"21","author":"Pollio","year":"2018","journal-title":"Vet Ophthalmol"},{"key":"10.1016\/j.cvsm.2018.07.002_bib81","first-page":"309","article-title":"The use of intravenous lipid emulsion as an antidote in veterinary toxicology","volume":"21","author":"Fernandez","year":"2011","journal-title":"J\u00a0Vet Emerg Crit Care (San Antonio)"},{"key":"10.1016\/j.cvsm.2018.07.002_bib82","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3109\/15563650.2016.1151528","article-title":"Systematic review of clinical adverse events reported after acute intravenous lipid emulsion administration","volume":"54","author":"Hayes","year":"2016","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1016\/j.cvsm.2018.07.002_bib83","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3109\/15563650.2015.1126286","article-title":"Systematic review of the effect of intravenous lipid emulsion therapy for non-local anesthetics toxicity","volume":"54","author":"Levine","year":"2016","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1016\/j.cvsm.2018.07.002_bib84","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.cvsm.2016.10.018","article-title":"Lipid therapy for intoxications","volume":"47","author":"Robben","year":"2017","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"10.1016\/j.cvsm.2018.07.002_bib85","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1757-7241-18-51","article-title":"Intravenous lipid emulsion in clinical toxicology","volume":"18","author":"Rothschild","year":"2010","journal-title":"Scand J Trauma Resusc Emerg Med"},{"key":"10.1016\/j.cvsm.2018.07.002_bib86","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00424-002-0999-2","article-title":"Cholinergic modulation of the cortical neuronal network","volume":"446","author":"Lucas-Meunier","year":"2003","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.cvsm.2018.07.002_bib87","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s11259-007-0050-3","article-title":"The effect of ivermectin on convulsions in rats produced by lidocaine and strychnine","volume":"31","author":"Trailovic","year":"2007","journal-title":"Vet Res Commun"},{"key":"10.1016\/j.cvsm.2018.07.002_bib88","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0195-5616(01)00008-0","article-title":"Newer antidotal therapies","volume":"32","author":"Gwaltney-Brant","year":"2002","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"10.1016\/j.cvsm.2018.07.002_bib89","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.cvsm.2006.05.006","article-title":"Pharmacogenetics","volume":"36","author":"Mealey","year":"2006","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"10.1016\/j.cvsm.2018.07.002_bib90","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.2460\/javma.2003.223.1453","article-title":"Increased toxicity of P-glycoprotein-substrate chemotherapeutic agents in a dog with the MDR1 deletion mutation associated with ivermectin sensitivity","volume":"223","author":"Mealey","year":"2003","journal-title":"J\u00a0Am Vet Med Assoc"},{"key":"10.1016\/j.cvsm.2018.07.002_bib91","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.toxlet.2004.12.008","article-title":"Does inhibition of P-glycoprotein lead to drug-drug interactions?","volume":"156","author":"Balayssac","year":"2005","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.cvsm.2018.07.002_bib92","unstructured":"Joint WHO\/FAO Expert Committee on Food Additives. 696. Ivermectin (WHO\u00a0Food Additives Series 27). 1991. Available at: http:\/\/www.inchem.org\/documents\/jecfa\/jecmono\/v27je03.htm. Accessed June 11, 2018."},{"key":"10.1016\/j.cvsm.2018.07.002_bib93","unstructured":"Roberts G. Joint WHO\/FAO Expert Committee on Food Additives. 854. Doramectin (WHO Food Additives Series 36). 1996. Available at: http:\/\/www.inchem.org\/documents\/jecfa\/jecmono\/v36je02.htm. Accessed June 11, 2018."},{"key":"10.1016\/j.cvsm.2018.07.002_bib94","series-title":"Heartgard Plus [package insert]","year":"2015"},{"key":"10.1016\/j.cvsm.2018.07.002_bib95","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0304-4017(00)00306-X","article-title":"Safety of selamectin in dogs","volume":"91","author":"Novotny","year":"2000","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.cvsm.2018.07.002_bib96","doi-asserted-by":"crossref","first-page":"482","DOI":"10.2460\/ajvr.2000.61.482","article-title":"Safety of moxidectin in avermectin-sensitive collies","volume":"61","author":"Paul","year":"2000","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.cvsm.2018.07.002_bib97","series-title":"ProHeart 6 [package insert]","year":"2016"},{"key":"10.1016\/j.cvsm.2018.07.002_bib98","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2460\/javma.2000.216.215","article-title":"Use of doramectin for treatment of notoedric mange in five cats","volume":"216","author":"Delucchi","year":"2000","journal-title":"J\u00a0Am Vet Med Assoc"},{"key":"10.1016\/j.cvsm.2018.07.002_bib99","series-title":"Interceptor plus [package insert]","year":"2017"},{"key":"10.1016\/j.cvsm.2018.07.002_bib100","series-title":"Revolution topical parasiticide for dogs and cats [package insert]","year":"2014"},{"key":"10.1016\/j.cvsm.2018.07.002_bib101","series-title":"Advantage multi for cats topical solution [package insert]","year":"2015"},{"key":"10.1016\/j.cvsm.2018.07.002_bib102","series-title":"Advantage multi for dogs topical solution [package insert]","year":"2015"},{"key":"10.1016\/j.cvsm.2018.07.002_bib103","unstructured":"Woodward K. Joint WHO\/FAO Expert Committee on Food Additives. 855. Moxidectin (WHO Food Additives Series 36). 1996. Available at: http:\/\/www.inchem.org\/documents\/jecfa\/jecmono\/v36je03.htm. Accessed June 11, 2018."}],"container-title":["Veterinary Clinics of North America: Small Animal Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0195561618300810?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0195561618300810?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T12:47:43Z","timestamp":1751806063000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0195561618300810"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":103,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S0195561618300810"],"URL":"https:\/\/doi.org\/10.1016\/j.cvsm.2018.07.002","relation":{},"ISSN":["0195-5616"],"issn-type":[{"value":"0195-5616","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Toxicology of Avermectins and Milbemycins (Macrocyclic Lactones) and the Role of P-Glycoprotein in Dogs and Cats","name":"articletitle","label":"Article Title"},{"value":"Veterinary Clinics of North America: Small Animal Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cvsm.2018.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}